Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

被引：0
|
作者：
Laura C. Coates
Johan K. Wallman
Dennis McGonagle
Georg A. Schett
Iain B. McInnes
Philip J. Mease
Lawrence Rasouliyan
Erhard Quebe-Fehling
Darren L. Asquith
Andreas E. R. Fasth
Luminita Pricop
Corine Gaillez
机构：
[1] University of Oxford,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre
[2] Lund University,Department of Clinical Sciences Lund, Rheumatology, Skåne University Hospital
[3] University of Leeds,undefined
[4] University of Erlangen-Nuremberg,undefined
[5] University of Glasgow,undefined
[6] Swedish Medical Centre and University of Washington,undefined
[7] RTI Health Solutions,undefined
[8] Novartis Pharma AG,undefined
[9] Novartis Pharmaceuticals UK Ltd.,undefined
[10] Novartis Sverige AB,undefined
[11] Novartis Pharmaceuticals Corporation,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Psoriatic arthritis; Enthesitis; Secukinumab; Interleukin 17A inhibitor; Anti-TNF; Biologics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
    Kaeley, Gurjit S.
    Schett, Georg
    Conaghan, Philip G.
    McGonagle, Dennis
    Behrens, Frank
    Goupille, Philippe
    Gaillez, Corine
    Parikh, Bhumik
    Bakewell, Catherine
    [J]. RHEUMATOLOGY, 2024, 63 (01) : 41 - 49
  • [42] Secukinumab: A Review of Safety and Efficacy in Psoriatic Arthritis
    Hashim, Peter W.
    Papp, Kim A.
    Mease, Philip J.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (08) : S118 - S120
  • [43] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF TWO PHASE 3, RANDOMIZED, CONTROLLED TRIALS (FUTURE 1 AND FUTURE 2)
    Mease, P.
    McInnes, I. B.
    Richards, H.
    Pricop, L.
    Widmer, A.
    Mpofu, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 870 - 871
  • [44] PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS
    Baraliakos, X.
    Pournara, E.
    Gladman, D. D.
    Mease, P. J.
    Jahandideh, S.
    Coates, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 879 - 879
  • [45] Impact of Uric Acid Levels on Clinical and Radiographic Characteristics in Psoriatic Arthritis and Response to Secukinumab: A Pooled "Post Hoc" Analysis from Five Phase 3 Studies
    Felten, Renaud
    Widawski, Laura
    Spielmann, Lionel
    Gaillez, Corine
    Bao, Weibin
    O'Neill, Hugh
    Gottenberg, Jacques-Eric
    Duret, Pierre-Marie
    Messer, Laurent
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1988 - 1991
  • [46] Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients
    Gottlieb, Alice B.
    Mease, Philip J.
    Kirkham, Bruce
    Nash, Peter
    Balsa, Alejandro
    Combe, Bernard
    Rech, Juergen
    Martin, Ruvie
    Ligozio, Gregory
    Abrams, Ken
    Pricop, Luminita
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela
    Helliwell, Philip S.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3774 - 3776
  • [48] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN ANKYLOSING SPONDYLITIS PATIENTS: A POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 TRIALS
    Deodhar, Atul
    Schett, Georg
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Gensler, Lianne
    Ostergaard, Mikkel
    Agawane, Shital
    Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Porter, Brian
    Shete, Abhijit
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 7 - 7
  • [49] ULTRASOUND DEMONSTRATES CONTINUED IMPROVEMENT IN PSORIATIC ARTHRITIS SYNOVITIS AND ENTHESITIS WITH SECUKINUMAB: 52-WEEK RESULTS FROM A PHASE 3 STUDY
    Conaghan, Philip G.
    D'Agostino, Maria A.
    Schett, Georg
    Guerrero, Carlos
    Hanova, Petra
    Cazenave, Tomas
    Stoenoiu, Maria S.
    Backhaus, Marina
    Mouterde, Gael
    Boers, Maarten
    Duggan, Anne-Marie
    Goyanka, Punit
    Gaillez, Corine
    [J]. RHEUMATOLOGY, 2022, 61 : I139 - I139
  • [50] SECUKINUMAB SAFETY AND TOLERABILITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM A POOLED SAFETY ANALYSIS OF SEVEN INTERNATIONAL PHASE 3 TRIALS
    Soriano, Enrique
    Gottlieb, Alice
    McInnes, Ian B.
    Mease, Philip
    Mpofu, Shephard
    Widmer, Albert
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 140 - 140
12345